Division Head (Discovery II)

4D Pharma Research Limited
Job Location
United Kingdom
Job Description

The Division Head of Discovery II will lead a well-established senior scientific team. They will be responsible for planning and directing research projects investigating microbe characteristics and host responses of live biotherapeutic candidates progressing to the clinic. In particular, they will lead the research team to define mechanism of action of selected LBPs in novel disease areas using appropriate preclinical models and readouts. The successful applicant should ideally have solid knowledge of the gut microbiome and host-microbe interactions. The Division Head will be responsible for planning and directing the research projects within the planned resources and staff. They should have the ability to blend an understanding of preclinical science and translational research and be experienced in providing leadership to a group of scientists.

  • PhD in immunology, microbiology or other relevant discipline
  • Experience in an appropriate sector of the pharmaceutical or biotechnology industry
  • Experience of designing translational research programmes enabling progression into clinical trials
  • Background in human gut microbiome research and/or characterizing microbe-host interactions
  • Experience with managing an experienced research team
About Our Organization

4D Pharma PLC is a pharmaceutical company focussed on developing therapeutics from the human gut microbiome. Live biotherapeutic products (LBPs) derived from the gut microbiome represent a new class of drugs that contain live organisms for the prevention, treatment or cure of disease. 4D Pharma is a world leader in the LBP field and currently has two clinical stage programmes (in IBS and IBD) and a strong pipeline of pre-clinical programmes in autoimmunity, inflammation, oncology and CNS disease.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.

Social scientists report that the image of the 'lone scientist' might be deterring US students from STEM careers.